Abstract:
Objective To explore the feasibility, safety and clinical application value of single-port inflatable endoscopic by the axillary approach in the treatment of breast diseases.
Methods The clinical data of 84 patients with breast diseases received single-port inflatable endoscopic by the axillary approach breast surgery from December 2020 to March 2022 in Tianjin Medical University Cancer Institute & Hospital were analyzed retrospectively and followed up. The clinical characteristics, intraoperative and postoperative recovery, postoperative satisfaction scores, and local recurrence and distant metastasis were evaluated.
Results The operations in 84 patients were successfully completed without the requirement for conversion to open surgery. The score of postoperative breast satisfaction was (8.25
\pm 
1.21). There were no major complications such as incision infection and necrosis of incision margin after operation. During the follow-up period of 8–23 months, none of the patients showed local recurrence or tumor metastasis.
Conclusions The single-port inflatable endoscopic by the axillary approach breast surgery is safe and efficient, with few complications and high patient satisfaction, and has a promising prospect in clinical application.